Clostridium difficile Colitis

ABSTRACT

Clostridium difficile enterocolitis is endemic in most modern hospitals. The spectrum of clinical presentation varies from the asymptomatic carrier state to fulminant colitis with toxic megacolon and perforation. Highly toxigenic and lethal strains of C. difficile have emerged worldwide. Medical treatment consists of discontinuing the precipitating antibiotic, supportive measures and bowel rest, and antibiotic treatment with metronidazole or vancomycin. Surgical treatment may be necessary in cases of fulminant disease. Subtotal colectomy with end ileostomy is the operation of choice.

KEYWORDS

Clostridium difficile - pseudomembranous enterocolitis - antibiotic-associated colitis

REFERENCES

• 1 Rolfe R D, Helebian S, Finegold S M. Bacterial interference between Clostridium difficile and normal fecal flora.  J Infect Dis. 1981;  143 470-475
• 2 Moyenuddin M, Williamson J C, Ohl C A. Clostridium difficile-associated diarrhea: current strategies for diagnosis and therapy.  Curr Gastroenterol Rep. 2002;  4 279-286
• 3 Gerding D N, Johnson S, Peterson L R et al.. Clostridium difficile-associated diarrhea and colitis.  Infect Control Hosp Epidemiol. 1995;  16 459-477
• 4 Warny M, Pepin J, Fang A et al.. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.  Lancet. 2005;  366 1079-1084
• 5 Severe Clostridium difficile-associated disease in populations previously at low risk-four states, 2005.  MMWR Morb Mortal Wkly Rep. 2005;  54 1201-1205
• 6 Hurley B W, Nguyen C C. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea.  Arch Intern Med. 2002;  162 2177-2184
• 7 Cleary R K. Clostridium difficile-associated diarrhea and colitis: clinical manifestations, diagnosis and treatment.  Dis Colon Rectum. 1998;  41 1435-1449
• 8 Viscidi R, Wiley S, Bartlett J G. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.  Gastroenterology. 1981;  81 5-9
• 9 Oldfield III E C. Clostridium difficile-associated diarrhea: resurgence with a vengeance.  Rev Gastroenterol Disord. 2006;  6 79-96
• 10 Hecht J R, Olinger E J. Clostridium difficile colitis secondary to intravenous vancomycin.  Dig Dis Sci. 1989;  34 148-149
• 11 Muto C A, Pokrywka M, Shutt K et al.. A large outbreak of Clostridium difficile-associated diarrhea with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.  Infect Control Hosp Epidemiol. 2005;  26 273-280
• 12 Pepin J, Saheb N, Coulombe M A et al.. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.  Clin Infect Dis. 2005;  41 1254-1260
• 13 Khurana A, Vinayek N, Recco R A et al.. The incidence of Clostridium difficile-associated diarrhea after use of gatifloxacin and levofloxacin in an acute care facility.  Clin Infect Dis. 2004;  39 602-603
• 14 Noren T. Outbreak from a high-toxin intruder: Clostridium difficile. Comment on: Lancet 2005;366:1079-1084.  Lancet. 2005;  366 1053-1054
• 15 Pepin J, Valiquette L, Alary M E et al.. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.  CMAJ. 2004;  171 466-472
• 16 Vesoulis Z, Williams G, Matthews B. Pseudomembranous enteritis after proctocolectomy.  Dis Colon Rectum. 2000;  43 551-554
• 17 Gonenne J, Pardi D S. Clostridium difficile: an update.  Compr Ther. 2004;  30 134-140
• 18 Schroeder M S. Clostridium difficile-associated diarrhea.  Am Fam Physician. 2005;  71 921-928
• 19 Bricker E, Garg R, Nelson R et al.. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.  Cochrane Database Syst Rev. 2005;  25(1) CD004610
• 20 Alcantara C S, Guerrant R L. Update on Clostridium difficile infection.  Curr Gastroenterol Rep. 2000;  2 310-314
• 21 Dendukuri N, Costa V, McGregor M, Brophy J M. Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review.  CMAJ. 2005;  173 167-170
• 22 McFarland L V. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.  Am J Gastroenterol. 2006;  101 812-822
• 23 Bowden Jr T A, Mansberger Jr A R, Lykins L E. Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis.  Am Surg. 1981;  47 178-183
• 24 Schwan A, Sjolin S, Trottestam U et al.. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces.  Scand J Infect Dis. 1984;  16 211-215
• 25 Persky S E, Brandt L J. Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through the colonoscope.  Am J Gastroenterol. 2000;  95 3283-3285
• 26 Aas J, Gessert C E, Bakken J S. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.  Clin Infect Dis. 2003;  36 580-585
• 27 Huebner E S, Surawicz C M. Treatment of recurrent Clostridium difficile diarrhea.  Gastroenterol Hepatol. 2006;  2 203-208
• 28 Grundfest-Broniatowski S, Quader M, Alexander F et al.. Clostridium difficile colitis in the critically ill.  Dis Colon Rectum. 1996;  39 619-623
• 29 Trudel J L, Deschenes M, Mayrand S et al.. Toxic megacolon complicating pseudomembranous enterocolitis.  Dis Colon Rectum. 1995;  38 1033-1038
• 30 Dallal R M, Harbrecht B G, Boujoukas A J et al.. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications.  Ann Surg. 2002;  235 363-372
• 31 Jobe B A, Grasley A, Deveney K E et al.. Clostridium difficile colitis: an increasing hospital-acquired illness.  Am J Surg. 1995;  169 480-483
• 32 Lipsett P A, Samantaray D K, Tam M L et al.. Pseudomembranous colitis: a surgical disease?.  Surgery. 1994;  116 491-496
• 33 Medich D S, Lee K KW, Simmons R L et al.. Laparotomy for fulminant pseudomembranous colitis.  Arch Surg. 1992;  127 847-853
• 34 Morris J B, Zollinger R M, Stellato T A. The role of surgery in antibiotic-induced pseudomembranous enterocolitis.  Am J Surg. 1990;  160 535-539